Clinical Diabetes 25:1-2, 2007
© American Diabetes Association ®, Inc., 2007
Diabetes and C-Reactive Protein
Tom Elasy, MD, MPH, Editor-in-Chief
| The first 20% of the full text of this article appears below. |
Since Celsus ( 50 BC), who is credited with describing
rubor, calor, dolor, and tumor as key attributes of
inflammation, pathology has been a foundational study of physicians. The study
of the structural and functional processes that underlie disease has always
engaged physicians in much the same way that disturbances in economies would
attract economists. And, like other professionals, our observations about
processes beget inferences that occasionally beget predictions that
occasionally beget recommendations.
In this issue, we see several attempts to understand or respond to the
processes that underlie dysfunction. At a forest level, Robb Malone, PharmD,
CDE, CPP; Betsy Bryant Shilliday, PharmD, CDE, CPP; Timothy J. Ives, PharmD,
MPH; and Michael Pignone, MD, MPH
(p. 31) describe an
attempt to improve care at a large hospital in North Carolina based on
perceived dysfunctions in the system that delivers care. With this elegant and
detailed description of an attempt to improve . . . [Full Text of this Article]

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Related Articles:
-
C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge
- David M. Capuzzi and Jeffrey S. Freeman
Clin. Diabetes 2007 25: 16-22.
[Abstract]
[Full Text]
[PDF]
-
Diabetes: Magnitude and Mechanisms
- Michael J. Fowler
Clin. Diabetes 2007 25: 25-28.
[Extract]
[Full Text]
[PDF]
-
Development and Evolution of a Primary Care-Based Diabetes Disease Management Program
- Robb Malone, Betsy Bryant Shilliday, Timothy J. Ives, and Michael Pignone
Clin. Diabetes 2007 25: 31-35.
[Extract]
[Full Text]
[PDF]
Copyright © 2007 by the American Diabetes Association.
|
|
|